Navigation Links
Consistent National Standards For Assessment Of Overseas Trained Doctors A Priority

AMA President, Dr Mukesh Haikerwal, said today that the lack of consistent national standards and processes for assessing the skills// and experience of overseas trained doctors (OTDs) is diminishing confidence in the quality of medicine in Australia and diluting the effectiveness of the important contribution that OTDs make to the health system.

Dr Haikerwal said the system must be rigorous and fair to ensure the community gets expert medical care from doctors who have proven themselves to be fit for the task assigned to them.

"The system is an absolute shambles at the moment," Dr Haikerwal said.

"It is wasting important resources, especially in country areas, and it is a huge disincentive to overseas trained doctors who are keen to work in areas of health need.

"The Commonwealth has tried to achieve consensus among the States and Territories to implement nationally consistent standards and processes to assess overseas trained doctors going into general practice, but the process is falling victim to 'patch protection' with almost every State wanting their own system.

"Unless all Governments take this issue seriously and reach agreement on a single national assessment process, we will end up with a meaningless standard that is based on the lowest common denominator.

"We want to see the Commonwealth toughen up its current work on overseas trained doctor assessment, which is due to be announced later in the year.

"Our concern is that proposals to be considered by the States and Territories will be voluntary.

"This is not good enough. Ultimately the adoption of supervision guidelines, implementation of an offshore screening exam, and standardised paperwork requirements must be compulsory and binding on all States and Territories.

"Otherwise, OTDs will still face the current nightmare where some States will accept their qualifications while others won't."
'"/>




Page: 1 2

Related medicine news :

1. National Lung Study in the process
2. Indian Nationals with Foreign Medical Degrees can now practice in India
3. Hepatitis B Vaccine To Be Included In National Immunization Programme
4. UK Govt Says On Course For National Chlamydia Screening
5. Mexico and US border attain a new outlook due to BiNational Sustainability Laboratory
6. India extends National TB Control Program
7. President and Founder of National Obesity Forum Resigns
8. Hwang Woo Suk Suspended By Seoul National University
9. Indian National in Saudi Jail will be released soon
10. National Women and Girls HIV/AIDS Awareness Day
11. Calcutta National Medical College Strike Continues Unabated
Post Your Comments:
Breaking Medicine Technology:Circassia Raises GBP15 Million ($25 Million) in Oversubscribed Investment Round 2Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 2Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 5Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 2Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 3Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 4Sinovac Establishes Joint Venture to Expand Human Use Vaccine Development and Manufacturing Capabilities 14977 1Sinovac Establishes Joint Venture to Expand Human Use Vaccine Development and Manufacturing Capabilities 14977 2Sinovac Establishes Joint Venture to Expand Human Use Vaccine Development and Manufacturing Capabilities 14977 3Abaxis Inc to Present at the 21st Annual Piper Jaffray Health Care Conference 6535 1Cempra Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 6531 1